The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Small Business Innovation Research (SBIR) program, Phase I |
93.433 |
HHS-2022-ACL-NIDILRR-BISA-0019 |
| Small Business Innovation Research Program (SBIR) Phase II |
93.433 |
HHS-2022-ACL-NIDILRR-BISB-0020 |
| Rehabilitation Engineering Research Centers (RERC) Program: RERC on Rehabilitation Strategies, Techniques, and Interventions |
93.433 |
HHS-2022-ACL-NIDILRR-REGE-0024 |
| Rehabilitation Research and Training Centers (RRTC): Equity Center in the Employment Domain |
93.433 |
HHS-2022-ACL-NIDILRR-RTEM-0028 |
| Rehabilitation Research and Training Centers (RRTC): Equity Center in the Health and Function Domain |
93.433 |
HHS-2022-ACL-NIDILRR-RTHF-0029 |
| Rehabilitation Research and Training Centers (RRTC): Equity Center in the Community Living and Participation Domain |
93.433 |
HHS-2022-ACL-NIDILRR-RTCP-0026 |
| Rehabilitation Engineering Research Centers (RERC) Program: RERC on Recreational, Sport, and Exercise Technologies for People with Disabilities |
93.433 |
HHS-2022-ACL-NIDILRR-REGE-0000 |
| Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) |
93.394, 93.395 |
RFA-CA-21-038 |
| Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed) |
93.394, 93.395 |
RFA-CA-21-039 |
| NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) |
93.853 |
PAR-21-266 |
| NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
93.855 |
PAR-21-258 |
| NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) |
93.853 |
PAR-21-267 |
| Field Initiated Projects Program (Research) |
93.433 |
HHS-2022-ACL-NIDILRR-IFRE-0009 |
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
93.855 |
PAR-21-276 |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) |
93.853 |
PAR-21-265 |
| Office of Elementary and Secondary Education (OESE): Effective Educator Development (EED) Program: American History and Civics Education National Activities (AHC-NA) Program Assistance Listing Number (ALN) 84.422B |
84.422 |
ED-GRANTS-071921-002 |
| Primary Care-Based Screening and Intervention Development for Prevention of Abuse in Older and Vulnerable Adults in the Context of Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Required) |
93.866 |
RFA-AG-22-024 |
| Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Biostatistics Research Center (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-003 |
| Aging Research in Animals (ARIA): Promoting Rigorous Research on Behavioral and Social Processes (R61/R33 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-015 |
| Evaluation of Citizens Crime Commission's (CCC) Disruption and Early Engagement Program (DEEP) Initiative |
97.108 |
DHS-ST-21-208-FR06 |
| Elucidating the Roles of Transposable Elements in AD/ADRD and Aging (R01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-22-021 |
| Continuation of The Collaborative Islet Transplantation Registry (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-013 |
| Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) |
93.121, 93.350, 93.837, 93.846, 93.847, 93.853, 93.855, 93.866, 93.867 |
RFA-HL-22-014 |
| BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-21-205 |
| Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes Clinical Centers (U01 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-21-002 |
| Implementing Pre-exposure Prophylaxis for HIV Prevention in Syringe Service Programs |
93.084, 93.941 |
RFA-PS-22-001 |
| Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) |
93.172, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855 |
PAR-21-247 |
| Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed) |
93.395, 93.396 |
PAR-21-274 |
| Network of the National Library of Medicine All of Us Program Center (U24) (Clinical Trial Optional) |
93.879 |
RFA-LM-21-002 |
| Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed) |
93.865 |
PAR-21-248 |
| Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern (U19 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-050 |
| Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) |
93.226 |
PA-22-048 |
| Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans) |
93.121, 93.242, 93.273, 93.279, 93.307, 93.313, 93.399, 93.865, 93.866 |
PAR-21-280 |
| NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) |
93.242 |
PAR-21-239 |
| Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) |
93.226 |
PA-22-047 |
| Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18) |
93.226 |
PA-21-267 |
| Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) |
93.279 |
RFA-DA-23-001 |
| Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial not allowed) |
93.172 |
RFA-HG-21-002 |
| Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) |
93.121, 93.242, 93.273, 93.279, 93.307, 93.313, 93.399, 93.865, 93.866 |
PAR-21-281 |
| Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial not allowed) |
93.172 |
RFA-HG-21-001 |
Search Results 3601-3640 of 21438
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 [Next] |
